Multiple sclerosis trials in South Africa

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

  Where

  Cape Town, Pretoria

  Age

  40 years to 70 years

  People

  400 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06846281 · EU 2023-509275-17-00
• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Where

  Cape Town

  Age

  18 years to 65 years

  People

  1,275 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07225504